Table 4.
Model 1 | Model 2 | Model 3 | ||||
---|---|---|---|---|---|---|
Hazard Ratio (95% CI) | P value | Hazard Ratio (95% CI) | P value | Hazard Ratio (95% CI) | P value | |
No AS and no MS | Reference | Reference | Reference | |||
No AS and MS | 2.48 (0.93–6.60) | 0.069 | 2.17 (0.75–6.28) | 0.151 | 2.38 (0.77–7.38) | 0.134 |
AS and no MS | 3.86 (1.12–13.28) | 0.032* | 5.48 (1.50–20.05) | 0.010* | 6.54 (1.67–25.68) | 0.007* |
AS and MS | 7.38 (2.61–20.83) | < 0.001* | 8.23 (2.46–27.86) | < 0.001* | 10.20 (2.77–37.53) | < 0.001* |
Notes: Model 1 is adjusted for age, waist circumference, and body mass index. Model 2 is adjusted for the model 1 variables and for systolic blood pressure, triglycerides, high-density lipoprotein cholesterol, fasting glucose, insulin, and homeostasis model assessment of insulin resistance. Model 3 is adjusted for the model 2 variables and for blood urea nitrogen, creatinine, glomerular filtration rate, total calcium, phosphorus, and calcium-phosphorous product. *P < 0.05 was considered statistically significant.
Abbreviations: AS, arterial stiffness; MS, metabolic syndrome; CI, confidence interval.